HomeCompareBSCT vs JNJ

BSCT vs JNJ: Dividend Comparison 2026

BSCT yields 4.58% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BSCT wins by $7.0K in total portfolio value
10 years
BSCT
BSCT
● Live price
4.58%
Share price
$18.66
Annual div
$0.85
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.0K
Annual income
$613.67
Full BSCT calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BSCT vs JNJ

📍 BSCT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBSCTJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BSCT + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BSCT pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BSCT
Annual income on $10K today (after 15% tax)
$389.05/yr
After 10yr DRIP, annual income (after tax)
$521.62/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $181.99/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BSCT + JNJ for your $10,000?

BSCT: 50%JNJ: 50%
100% JNJ50/50100% BSCT
Portfolio after 10yr
$23.5K
Annual income
$720.73/yr
Blended yield
3.07%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BSCT
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BSCT buys
0
JNJ buys
0
No recent congressional trades found for BSCT or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBSCTJNJ
Forward yield4.58%3.36%
Annual dividend / share$0.85$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$27.0K$20.0K
Annual income after 10y$613.67$827.78
Total dividends collected$5.4K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BSCT vs JNJ ($10,000, DRIP)

YearBSCT PortfolioBSCT Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,158$457.71$10,676$355.77+$482.00BSCT
2$12,416$477.29$11,407$389.39+$1.0KBSCT
3$13,782$496.37$12,198$426.53+$1.6KBSCT
4$15,261$514.91$13,056$467.62+$2.2KBSCT
5$16,862$532.89$13,987$513.12+$2.9KBSCT
6$18,593$550.28$14,998$563.56+$3.6KBSCT
7$20,462$567.07$16,098$619.52+$4.4KBSCT
8$22,477$583.23$17,295$681.69+$5.2KBSCT
9$24,649$598.77$18,599$750.82+$6.0KBSCT
10$26,988$613.67$20,022$827.78+$7.0KBSCT

BSCT vs JNJ: Complete Analysis 2026

BSCTStock

The Invesco BulletShares 2029 Corporate Bond ETF (Fund) is based on the Invesco BulletShares Corporate Bond 2029 Index (Index). The Fund will invest at least 80% of its total assets in corporate bonds that comprise the index. The Index seeks to measure the performance of a portfolio of US dollar-denominated, investment-grade corporate bonds with effective maturities in 2029. The Fund does not purchase all of the securities in the Index; instead, the Fund utilizes a "sampling" methodology to seek to achieve its investment objective. The Fund and the Index are rebalanced monthly. The Fund has a designated year of maturity of 2029 and will terminate on or about Dec. 15, 2029. See the prospectus for more information.Effective Jan. 1, 2024, the Underlying Index name changed from the Nasdaq BulletShares USD Corporate Bond 2029 Index to the Invesco BulletShares Corporate Bond 2029 Index. See the prospectus for more information.

Full BSCT Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BSCT vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BSCT vs SCHDBSCT vs JEPIBSCT vs OBSCT vs KOBSCT vs MAINBSCT vs ABBVBSCT vs MRKBSCT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.